# Plantagoside Alleviate Hepatic Inflammation, Oxidative Stress and Histopathological Damage in D‐Galactose‐Induced Senescent Mice by Modulating Purine Metabolic Pathways

**Authors:** Jinjia Liu, Yuning Zhang, Furong Lv, Chengming Wang, Jixiang Wang, Lijuan Li, Jinqiang Wu, Lina Lai

PMC · DOI: 10.1002/fsn3.71153 · Food Science & Nutrition · 2025-10-31

## TL;DR

Plantagoside helps protect the liver from aging-related damage by reducing inflammation and oxidative stress in mice.

## Contribution

This study reveals a novel mechanism by which plantagoside protects the liver through regulation of purine metabolism.

## Key findings

- PLA reduced oxidative stress and inflammation in D-gal-induced senescent mice.
- Transcriptomic and metabolomic analyses showed PLA regulates purine metabolism and the PI3K-Akt pathway.
- PLA improved liver health and antioxidant capacity, suggesting potential as an anti-aging drug.

## Abstract

In this study, we aimed to investigate the hepatoprotective effects of plantagoside (PLA) against D‐galactose (D‐gal)‐induced liver injury in aged mice. PLA treatment significantly alleviated the D‐gal‐induced body weight loss and the elevated liver index in mice, and effectively reduced oxidative stress, inflammatory response, and liver tissue damage in vivo. Transcriptomic analysis identified 513 differentially expressed genes (DEGs) regulated by PLA, and enrichment analysis revealed that these genes were primarily associated with the PI3K‐Akt signaling pathway and purine metabolism. Metabolomic analysis revealed that PLA regulates purine metabolism by modulating key metabolites, such as hypoxanthine and cAMP. Integrated omics analysis suggested that PLA exerts protective effects by regulating purine metabolism, thereby enhancing antioxidant capacity and suppressing inflammation. In conclusion, PLA significantly alleviated D‐gal‐induced liver injury, reduced oxidative stress, and attenuated inflammation by regulating purine metabolism, thereby demonstrating its potential as an anti‐aging and hepatoprotective drug and providing a new theoretical basis for the treatment of age‐associated liver diseases.

Protective role of plantagoside in D‐galactose‐induced hepatic aging through regulation of purine metabolism.

## Linked entities

- **Chemicals:** plantagoside (PubChem CID 174157), D-galactose (PubChem CID 206), hypoxanthine (PubChem CID 135398638), cAMP (PubChem CID 6076)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}
- **Diseases:** liver injury (MESH:D017093), liver diseases (MESH:D008107), Hepatic (MESH:D056486), weight loss (MESH:D015431), Inflammation (MESH:D007249)
- **Chemicals:** D-Galactose (MESH:D005690), cAMP (-), hypoxanthine (MESH:D019271), PLA (MESH:C062295)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12578599/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12578599/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC12578599/full.md

---
Source: https://tomesphere.com/paper/PMC12578599